5-Propyl-2-deoxyuridine induced interference with glycosylation in herpes simplex virus infected cells
- 1 September 1993
- journal article
- Published by Springer Nature in Archiv für die gesamte Virusforschung
- Vol. 128 (3-4), 241-256
- https://doi.org/10.1007/bf01309437
Abstract
In herpes simplex virus-infected (HSV) cells, the antiviral nucleoside analogue 5-n-propyl-2′-deoxyuridine (PdU) may, under certain circumstances, induce a pattern of interference with late steps in formation of N-linked glycans, resulting in increased availability of viral glycoproteins for neutralizing antibodies. The PdU-induced changes in N-linked glycans, released by pronase digestion of the HSV-specified glycoprotein gC-1, were investigated by using lectin affinity chromatography and Bio-Gel P6 gel filtration of glycans, radiolabelled with [3H]galactose or [3H]glucosamine. PdU-treatment of HSV-infected cells totally inhibited addition of sialic acid and reduced the amount of galactose incorporated into N-linked glycans by 70%. In addition, the PDU-treatment caused a decrease in oligosaccharides with affinity forPhaseoulus vulgaris leuco-agglutinin and erythro-agglutinin, and an increase inLens culinaris lectin (LCA)-binding oligosaccharides, suggesting a PdU-induced shift from multi-branched to moderately branched structures. This shift was also found in HSV-infected B16 mouse melanoma cells, where the large content of multi-branched oligosaccharides contributes to the metastatic potential. The LCA-binding glycans from PdU-treated cells were smaller and contained less galactose units than corresponding structures from untreated cells. In a cell-free system, PdU 5′-monophosphate inhibited the translocation of UDP-GlcNAc, and, to a smaller extent, also the translocation of UDP-galactose into Golgi vesicles, suggesting that nucleotide sugar translocation is one important target for the PdU-induced interference with glycosylation in HSV-infected cells.Keywords
This publication has 34 references indexed in Scilit:
- Selective Induction of Discrete Epitopes of Herpes Simplex Virus Type 1-Specified Glycoprotein C by Interference with Terminal Steps in GlycosylationJournal of General Virology, 1991
- Activity of herpes simplex virus type 1-specified glycoprotein C antigenic site II epitopes reversibly modulated by peripheral fucose or galactose units of glycoprotein oligosaccharidesJournal of General Virology, 1990
- Demonstration and Mapping of Highly Carbohydrate-dependent Epitopes in the Herpes Simplex Virus Type 1-Specified Glycoprotein CJournal of General Virology, 1987
- Inhibitors of protein glycosylation and glycoprotein processing in viral systemsPharmacology & Therapeutics, 1987
- Carbohydrate Dramatically Influences Immune Reactivity of Antisera to Viral Glycoprotein AntigensScience, 1984
- Glycoprotein C of Herpes Simplex Virus Type 1: Characterization of O-linked OligosaccharidesJournal of General Virology, 1983
- Studies on benzhydrazone, a specific inhibitor of herpesvirus glycoprotein synthesis. Size distribution of glycopeptides and endo-?-N-acetylglucosaminidase-H treatmentArchiv für die gesamte Virusforschung, 1981
- Selective inhibition of herpes simplex virus glycoprotein synthesis by a benz-amidinohydrazone derivativeArchiv für die gesamte Virusforschung, 1980
- Isolation of a Golgi-rich fraction from rat liverBiochimica et Biophysica Acta (BBA) - Biomembranes, 1970
- Notes. A Nonmutagenic Thymidine Analog with Antiviral Activity. 5-EthyldeoxyuridineJournal of Medicinal Chemistry, 1969